Evidence of Insulin Resistance and Other Metabolic Alterations in Boys with Duchenne or Becker Muscular Dystrophy
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2015, 1-8
Abstract
Aim. Our aim was (1) to determine the frequency of insulin resistance (IR) in patients with Duchenne/Becker muscular dystrophy (DMD/BMD), (2) to identify deleted exons of DMD gene associated with obesity and IR, and (3) to explore some likely molecular mechanisms leading to IR.Materials and Methods. In 66 patients with DMD/BMD without corticosteroids treatment, IR, obesity, and body fat mass were evaluated. Molecules involved in glucose metabolism were analyzed in muscle biopsies. Results show that 18.3%, 22.7%, and 68% were underweight, overweight, or obese, and with high adiposity, respectively; 48.5% and 36.4% presented hyperinsulinemia and IR, respectively. Underweight patients (27.3%) exhibited hyperinsulinemia and IR. Carriers of deletions in exons 45 (OR = 9.32; 95% CI = 1.16–74.69) and 50 (OR = 8.73; 95% CI = 1.17–65.10) from DMD gene presented higher risk for IR than noncarriers. We observed a greater staining of cytoplasmic aggregates for GLUT4 in muscle biopsies than healthy muscle tissue.Conclusion. Obesity, hyperinsulinemia, and IR were observed in DMD/BMD patients and are independent of corticosteroids treatment. Carriers of deletion in exons 45 or 50 from DMD gene are at risk for developing IR. It is suggested that alteration in GLUT4 in muscle fibers from DMD patients could be involved in IR.Keywords
Funding Information
- Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/076, 711, FIS/IMSS/PROT/916)
- Instituto de Ciencia y Tecnología del Distrito Federal (FIS/IMSS/PROT/076, 711, FIS/IMSS/PROT/916)
- Association Française contre les Myopathies (FIS/IMSS/PROT/076, 711, FIS/IMSS/PROT/916)
This publication has 27 references indexed in Scilit:
- Metabolic syndrome risk factors in overweight, obese, and extremely obese brazilian adolescentsNutrition Journal, 2013
- Sarcoglycan ComplexJournal of Biological Chemistry, 2009
- Expression of the skeletal muscle dystrophin–dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto–Kakizaki ratEuropean Journal of Cell Biology, 2005
- The Dystrophin Glycoprotein ComplexCirculation Research, 2004
- Body composition and energy expenditure in Duchenne muscular dystrophyEuropean Journal of Clinical Nutrition, 2003
- ObesityNew England Journal of Medicine, 2002
- Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjectsMagnetic Resonance Imaging, 1997
- NUTRITIONAL ASSESSMENT IN DUCHENNE MUSCULAR DYSTROPHYDevelopmental Medicine & Child Neurology, 1993
- Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscleNature, 1990
- An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locusGenomics, 1988